EastWest Bioscience Inc.
EASTH.V
TSX
04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 15.60K | 19.10K | 783.60K | 846.60K | 96.20K |
Total Receivables | 63.40K | 88.10K | 57.40K | 66.00K | 299.50K |
Inventory | 168.40K | 134.00K | 173.60K | 164.40K | 159.90K |
Prepaid Expenses | 3.60K | 13.60K | 8.10K | 8.20K | 16.20K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 251.00K | 254.70K | 1.02M | 1.09M | 571.80K |
|
|||||
Total Current Assets | 251.00K | 254.70K | 1.02M | 1.09M | 571.80K |
Net Property, Plant & Equipment | 1.60M | 1.63M | 1.75M | 1.70M | 1.76M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 151.10K | 152.20K | 156.20K | 155.30K | 168.70K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 5.94M | 6.26M | 2.97M | 2.98M | 2.54M |
|
|||||
Total Accounts Payable | 457.60K | 376.70K | 468.50K | 399.10K | 372.90K |
Total Accrued Expenses | 581.60K | 638.00K | 740.70K | 509.90K | 547.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.59M | 1.60M | 1.64M | 1.64M | 1.67M |
Total Finance Division Other Current Liabilities | 312.10K | 208.30K | 300.70K | 191.30K | 74.70K |
Total Other Current Liabilities | 312.10K | 208.30K | 300.70K | 191.30K | 74.70K |
Total Current Liabilities | 2.94M | 2.82M | 3.15M | 2.74M | 2.67M |
|
|||||
Total Current Liabilities | 2.94M | 2.82M | 3.15M | 2.74M | 2.67M |
Long-Term Debt | 329.50K | 322.60K | 305.70K | 295.40K | 283.30K |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.27M | 3.14M | 3.46M | 3.04M | 2.95M |
|
|||||
Common Stock & APIC | 6.95M | 7.00M | 7.12M | 7.08M | 7.17M |
Retained Earnings | -4.48M | -4.07M | -8.01M | -7.81M | -8.10M |
Treasury Stock & Other | 200.90K | 184.60K | 170.80K | 373.10K | 516.70K |
Total Common Equity | 2.68M | 3.12M | -712.20K | -352.40K | -416.20K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 2.68M | 3.12M | -712.20K | -352.40K | -416.20K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | 230.50K | 298.70K | -- |
Total Equity | 2.68M | 3.12M | -481.70K | -53.70K | -416.20K |
|